Inhibiting

Researchers have made a significant breakthrough in Parkinson’s disease research. Their study reveals that inhibiting a specific enzyme, USP30, in a mouse model can protect dopamine-producing neurons. This finding halts the disease’s progression and opens the door to new therapeutic possibilities for the 10 million people affected by Parkinson’s worldwide.The findings have the potential to pave the way for new disease-modifying treatments for patients with Parkinson’s disease.A study published in Nature Communications by…

In vitro tests have shown that two substances, A5 and C1, derived from the total synthesis of apomorphine hydrochloride, inhibit glioblastoma cell proliferation, suppress tumor stem cell formation, and boost temozolomide’s effectiveness. Further research and in vivo studies are needed to confirm their potential as novel glioblastoma treatments.In vitro tests were performed with cultured cells of glioblastoma, an aggressive type of cancer with few treatment options. The next step is to test the effects of the substances in…